-+ 0.00%
-+ 0.00%
-+ 0.00%

Lifecore Biomedical Q3 net loss widens to $40.08 million

PUBT·11/04/2026 12:19:18
Listen to the news
Lifecore Biomedical Q3 net loss widens to $40.08 million
  • Lifecore Biomedical’s third-quarter 2026 net loss widened to $40.08 million from a year earlier.
  • Revenues fell 19% year over year to $25.32 million.
  • Two technology-transfer projects secured during the quarter are expected to contribute to long-term revenue growth beginning in 2027.
  • Three development-phase programs secured early in the fourth quarter include one Phase 2 product and two Phase 3 products.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lifecore Biomedical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611040705PRIMZONEFULLFEED9869860) on November 04, 2026, and is solely responsible for the information contained therein.